Quick answers
- What is Human secretin used for?
- The FDA-approved label (ChiRhoStim, ChiRhoClin, Inc., October 8, 2025) says: “ChiRhoStim ® is indicated for the stimulation of: pancreatic secretions, including bicarbonate, to aid in the diagnosis of pancreatic exocrine dysfunction. gastrin secretion to aid in the diagnosis of gastrinoma, and pancreatic secretions to facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangiopancreatography (ERCP). …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Human secretin have a boxed warning?
- No. None of the 1 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Human secretin?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Human secretin been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Human secretin?
- 1 company lists prescription products of Human secretin in the FDA NDC Directory, including ChiRhoClin, Inc..
What Human secretin is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
ChiRhoStim ® is indicated for the stimulation of: pancreatic secretions, including bicarbonate, to aid in the diagnosis of pancreatic exocrine dysfunction. gastrin secretion to aid in the diagnosis of gastrinoma, and pancreatic secretions to facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangiopancreatography (ERCP). …
— FDA label: ChiRhoStim, ChiRhoClin, Inc., effective October 8, 2025. Read the full label on DailyMed →
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
Forms and how it is given
| Dosage forms | Injection, powder, lyophilized, for solution |
|---|---|
| Route | Intravenous |
| Prescription products | 2 in the FDA NDC Directory |
| Brand names | Chirhostim 40, Chirhostim |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- ChiRhoClin, Inc.2 products
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA021256 CHIRHOSTIM | Chirhoclin | April 9, 2004 | 5, latest July 18, 2017 2017: Labeling · 2015: Manufacturing (CMC) · 2007: Manufacturing (CMC) |
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 727488, 727492, 727494, 727496 |
|---|---|
| SPL set ID of the quoted label | b4dfe70f-0a86-4488-9ba1-dcd8f86cbfcd |
| FDA labels (SPL) | 1 |
| FDA applications | NDA021256 |
| Active ingredients (FDA) | SECRETIN HUMAN |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — ChiRhoStim, ChiRhoClin, Inc., effective October 8, 2025; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →